<DOC>
	<DOCNO>NCT00080041</DOCNO>
	<brief_summary>The primary purpose study evaluate safety , toxicity , dosage investigational drug Motexafin Gadolinium administer docetaxel patient advance solid tumor . Secondly , tumor response combine treatment evaluate .</brief_summary>
	<brief_title>Study Motexafin Gadolinium Docetaxel Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Motexafin gadolinium</mesh_term>
	<criteria>≥ 18 year old Histologically cytologically confirm diagnosis cancer ( i.e. , Unresectable locally advance metastatic nonsmallcell lung carcinoma ( NSCLC ) progress one chemotherapy regimens ; Metastatic breast cancer ; Hormonerefractory prostate cancer ; Recurrent refractory ovarian cancer ; Sarcoma ) ECOG performance status score either 0 1 Willing able provide write informed consent Laboratory Values : Absolute neutrophil count &lt; 2000/µL Platelet count &lt; 100,00/µL AST ALT &gt; 1.5 x upper limit normal Alkaline phosphatase &gt; 5 x upper limit normal Bilirubin &gt; ULN Creatinine &gt; 2.0 mg/dL Peripheral neuropathy NCI CTC Grade 3 high Chemotherapy , radiation therapy , immunotherapy , systemic biologic anticancer therapy within 21 day begin study treatment Known history brain metastasis spinal cord compression Uncontrolled hypertension Myocardial infarction within 6 month begin study treatment Unstable angina pectoris , uncontrolled congestive heart failure , uncontrolled serious arrhythmia Known sensitivity intolerable adverse effect taxanes polysorbate 80 Known history porphyria ( test require screening ) Known history glucose6phosphate dehydrogenase ( G6PD ) deficiency ( test require screening ) Known history HIV infection ( test require screening ) Female pregnant lactating ( pregnancy test require female patient childbearing potential ) Female childbearing potential sexually active male unwilling use adequate contraceptive protection Physical mental condition make patient unable complete specify followup assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Antineoplastic Combined Chemotherapy Protocols</keyword>
</DOC>